Surgery Partners, Inc. Income (Loss) from Equity Method Investments
Surgery Partners, Inc. (SGRY) reported Income (Loss) from Equity Method Investments of $6.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-10
- Surgery Partners, Inc. income (loss) from equity method investments for the quarter ending 2026-06-30 was $6.40M, a 16.36% increase year-over-year.
- Surgery Partners, Inc. income (loss) from equity method investments for the quarter ending 2026-03-31 was $4.10M, a 26.79% decline year-over-year.
- Surgery Partners, Inc. income (loss) from equity method investments for the quarter ending 2025-12-31 was $6.60M, a 8.33% decline year-over-year.
- Surgery Partners, Inc. income (loss) from equity method investments for the quarter ending 2025-09-30 was $5.20M, a 0.00% change year-over-year.
- Surgery Partners, Inc. income (loss) from equity method investments for fiscal 2025 was $22.90M, a 17.44% increase from fiscal 2024.
- Surgery Partners, Inc. income (loss) from equity method investments for fiscal 2024 was $19.50M, a 37.32% increase from fiscal 2023.
- Surgery Partners, Inc. income (loss) from equity method investments for fiscal 2023 was $14.20M, a 13.60% increase from fiscal 2022.
- Surgery Partners, Inc. income (loss) from equity method investments for fiscal 2022 was $12.50M, a 10.62% increase from fiscal 2021.
| Period end | Income (Loss) from Equity Method Investments 1 month | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 3 month as first filed | Income (Loss) from Equity Method Investments 4 month | Income (Loss) from Equity Method Investments 4 month as first filed | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 6 month as first filed | Income (Loss) from Equity Method Investments 8 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 9 month as first filed | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.40M 10-Q · filed 2026-08-10 | $10.50M 10-Q · filed 2026-08-10 | $17.10M derived: sum of 3 quarters · filed 2026-08-10 | $22.30M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||
| 2026-03-31 | $4.10M 10-Q · filed 2026-05-05 | $10.70M derived: sum of 2 quarters · filed 2026-05-05 | $15.90M derived: sum of 3 quarters · filed 2026-05-05 | $21.40M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||
| 2025-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $11.80M derived: sum of 2 quarters · filed 2026-03-02 | $17.30M derived: sum of 3 quarters · filed 2026-08-10 | $22.90M 10-K · filed 2026-03-02 | ||||||||
| 2025-09-30 | $5.20M 10-Q · filed 2025-11-10 | $10.70M derived: sum of 2 quarters · filed 2026-08-10 | $16.30M 10-Q · filed 2025-11-10 | $23.50M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||
| 2025-06-30 | $5.50M 10-Q · filed 2026-08-10 | $11.10M 10-Q · filed 2026-08-10 | $18.30M derived: sum of 3 quarters · filed 2026-08-10 | $23.50M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||
| 2025-03-31 | $5.60M 10-Q · filed 2026-05-05 | $12.80M derived: sum of 2 quarters · filed 2026-05-05 | $18.00M derived: sum of 3 quarters · filed 2026-05-05 | $22.40M derived: sum of 4 quarters · filed 2026-05-05 | ||||||||
| 2024-12-31 | $7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $12.40M derived: sum of 2 quarters · filed 2026-03-02 | $16.80M derived: sum of 3 quarters · filed 2026-03-02 | $19.50M 10-K · filed 2026-03-02 | ||||||||
| 2024-09-30 | $5.20M 10-Q · filed 2025-11-10 | $9.60M derived: sum of 2 quarters · filed 2025-11-10 | $12.30M 10-Q · filed 2025-11-10 | $17.10M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||
| 2024-06-30 | $4.40M 10-Q · filed 2025-08-05 | $7.10M 10-Q · filed 2025-08-05 | $11.90M derived: sum of 3 quarters · filed 2026-03-02 | $15.40M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||
| 2024-03-31 | $2.70M 10-Q · filed 2025-05-12 | $7.50M derived: sum of 2 quarters · filed 2026-03-02 | $11.00M derived: sum of 3 quarters · filed 2026-03-02 | $13.60M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||
| 2023-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $8.30M derived: sum of 2 quarters · filed 2026-03-02 | $10.90M derived: sum of 3 quarters · filed 2026-03-02 | $14.20M 10-K · filed 2026-03-02 | ||||||||
| 2023-09-30 | $3.50M 10-Q · filed 2024-11-12 | $6.10M derived: sum of 2 quarters · filed 2024-11-12 | $9.40M 10-Q · filed 2024-11-12 | $13.80M derived: sum of 4 quarters · filed 2025-03-07 | ||||||||
| 2023-06-30 | $2.60M 10-Q · filed 2024-08-06 | $5.90M 10-Q · filed 2024-08-06 | $10.30M derived: sum of 3 quarters · filed 2025-03-07 | $12.70M derived: sum of 4 quarters · filed 2025-03-07 | ||||||||
| 2023-03-31 | $3.30M 10-Q · filed 2024-05-07 | $7.70M derived: sum of 2 quarters · filed 2025-03-07 | $10.10M derived: sum of 3 quarters · filed 2025-03-07 | $12.70M derived: sum of 4 quarters · filed 2025-03-07 | ||||||||
| 2022-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $6.80M derived: sum of 2 quarters · filed 2025-03-07 | $9.40M derived: sum of 3 quarters · filed 2025-03-07 | $12.50M 10-K · filed 2025-03-07 | ||||||||
| 2022-09-30 | $2.40M 10-Q · filed 2023-11-07 | $5.00M derived: sum of 2 quarters · filed 2023-11-07 | $8.10M 10-Q · filed 2023-11-07 | $10.90M derived: sum of 4 quarters · filed 2024-02-26 | ||||||||
| 2022-06-30 | $2.60M 10-Q · filed 2023-08-01 | $5.70M 10-Q · filed 2023-08-01 | $8.50M derived: sum of 3 quarters · filed 2024-02-26 | $11.40M derived: sum of 4 quarters · filed 2024-02-26 | ||||||||
| 2022-03-31 | $3.10M 10-Q · filed 2023-05-02 | $5.90M derived: sum of 2 quarters · filed 2024-02-26 | $8.80M derived: sum of 3 quarters · filed 2024-02-26 | $11.80M derived: sum of 4 quarters · filed 2024-02-26 | ||||||||
| 2021-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $5.70M derived: sum of 2 quarters · filed 2024-02-26 | $8.70M derived: sum of 3 quarters · filed 2024-02-26 | $11.30M 10-K · filed 2024-02-26 | ||||||||
| 2021-09-30 | $2.90M 10-Q · filed 2022-11-08 | $5.90M derived: sum of 2 quarters · filed 2022-11-08 | $8.50M 10-Q · filed 2022-11-08 | $11.70M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2021-06-30 | $3.00M 10-Q · filed 2022-08-02 | $5.60M 10-Q · filed 2022-08-02 | $8.80M derived: sum of 3 quarters · filed 2023-03-01 | $11.90M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2021-03-31 | $2.60M 10-Q · filed 2022-05-03 | $5.80M derived: sum of 2 quarters · filed 2023-03-01 | $8.90M derived: sum of 3 quarters · filed 2023-03-01 | $11.40M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2020-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $6.30M derived: sum of 2 quarters · filed 2023-03-01 | $8.80M derived: sum of 3 quarters · filed 2023-03-01 | $10.80M 10-K · filed 2023-03-01 | ||||||||
| 2020-09-30 | $3.10M 10-Q · filed 2021-11-03 | $5.60M derived: sum of 2 quarters · filed 2021-11-03 | $7.60M 10-Q · filed 2021-11-03 | $11.20M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||
| 2020-06-30 | $2.50M 10-Q · filed 2021-08-04 | $4.50M 10-Q · filed 2021-08-04 | $8.10M derived: sum of 3 quarters · filed 2022-03-01 | $10.50M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||
| 2020-03-31 | $2.00M 10-Q · filed 2021-05-05 | $5.60M derived: sum of 2 quarters · filed 2022-03-01 | $8.00M derived: sum of 3 quarters · filed 2022-03-01 | $10.20M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||
| 2019-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.00M derived: sum of 2 quarters · filed 2022-03-01 | $8.20M derived: sum of 3 quarters · filed 2022-03-01 | $10.20M 10-K · filed 2022-03-01 | ||||||||
| 2019-09-30 | $2.40M 10-Q · filed 2020-11-04 | $4.60M derived: sum of 2 quarters · filed 2020-11-04 | $6.60M 10-Q · filed 2020-11-04 | $9.20M derived: sum of 4 quarters · filed 2021-03-10 | ||||||||
| 2019-06-30 | $2.20M 10-Q · filed 2020-08-05 | $4.20M 10-Q · filed 2020-08-05 | $6.80M derived: sum of 3 quarters · filed 2021-03-10 | $8.70M derived: sum of 4 quarters · filed 2021-03-10 | ||||||||
| 2019-03-31 | $2.00M 10-Q · filed 2020-05-11 | $4.60M derived: sum of 2 quarters · filed 2021-03-10 | $6.50M derived: sum of 3 quarters · filed 2021-03-10 | $9.00M derived: sum of 4 quarters · filed 2021-03-10 | ||||||||
| 2018-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $4.50M derived: sum of 2 quarters · filed 2021-03-10 | $7.00M derived: sum of 3 quarters · filed 2021-03-10 | $8.90M 10-K · filed 2021-03-10 | $8.90M 10-K · filed 2019-03-15 | |||||||
| 2018-09-30 | $1.90M 10-Q · filed 2019-11-06 | $1.86M 10-Q · filed 2018-11-09 | $4.40M derived: sum of 2 quarters · filed 2019-11-06 | $6.30M 10-Q · filed 2019-11-06 | $6.28M 10-Q · filed 2018-11-09 | |||||||
| 2018-06-30 | $2.50M 10-Q · filed 2019-08-09 | $2.56M 10-Q · filed 2018-08-09 | $4.40M 10-Q · filed 2019-08-09 | $4.42M 10-Q · filed 2018-08-09 | ||||||||
| 2018-03-31 | $1.90M 10-Q · filed 2019-05-10 | $1.86M 10-Q · filed 2018-05-10 | ||||||||||
| 2017-12-31 | $3.30M 10-K · filed 2020-03-13 | $3.32M 10-K · filed 2018-03-16 | ||||||||||
| 2017-09-30 | $712.00K 10-Q · filed 2018-11-09 | |||||||||||
| 2017-08-31 | $3.10M 10-K · filed 2020-03-13 | |||||||||||
| 2017-06-30 | $1.05M 10-Q · filed 2017-08-09 | $2.25M 10-Q · filed 2017-08-09 | $4.01M derived: sum of 3 quarters · filed 2017-08-09 | $5.18M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||
| 2017-03-31 | $1.20M 10-Q · filed 2017-05-10 | $2.96M derived: sum of 2 quarters · filed 2017-05-10 | $4.12M derived: sum of 3 quarters · filed 2017-05-10 | $5.21M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||
| 2016-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $2.92M derived: sum of 2 quarters · filed 2017-03-10 | $4.01M derived: sum of 3 quarters · filed 2017-08-09 | $4.76M 10-K · filed 2017-03-10 | ||||||||
| 2016-09-30 | $1.17M 10-Q · filed 2016-11-10 | $2.25M derived: sum of 2 quarters · filed 2017-08-09 | $3.01M 10-Q · filed 2016-11-10 | $3.92M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||
| 2016-06-30 | $1.08M 10-Q · filed 2017-08-09 | $1.84M 10-Q · filed 2017-08-09 | $2.75M derived: sum of 3 quarters · filed 2017-08-09 | $4.07M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||
| 2016-03-31 | $758.00K 10-Q · filed 2017-05-10 | $1.67M derived: sum of 2 quarters · filed 2017-05-10 | $2.99M derived: sum of 3 quarters · filed 2017-05-10 | $3.83M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||
| 2015-12-31 | $911.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $2.23M derived: sum of 2 quarters · filed 2017-03-10 | $3.07M derived: sum of 3 quarters · filed 2017-03-10 | $3.78M 10-K · filed 2017-03-10 | ||||||||
| 2015-09-30 | $1.32M 10-Q · filed 2016-11-10 | $2.16M derived: sum of 2 quarters · filed 2016-11-10 | $2.87M 10-Q · filed 2016-11-10 | $4.13M derived: sum of 4 quarters · filed 2017-03-10 | ||||||||
| 2015-06-30 | $839.00K 10-Q · filed 2016-08-10 | $1.55M 10-Q · filed 2016-08-10 | $2.81M derived: sum of 3 quarters · filed 2017-03-10 | $2.81M derived: sum of 4 quarters · filed 2017-03-10 | ||||||||
| 2015-03-31 | $707.00K 10-Q · filed 2016-05-06 | $1.97M derived: sum of 2 quarters · filed 2017-03-10 | $1.97M derived: sum of 3 quarters · filed 2017-03-10 | |||||||||
| 2014-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $1.26M derived: sum of 2 quarters · filed 2017-03-10 | $1.26M 10-K · filed 2017-03-10 | |||||||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | ||||||||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |